Robbins Farley’s Definium Therapeutics DFTX Stock Holding History

Robbins Farley’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.07K	Hold	28	–	–	﹤0.01%	139
2026 Q2	$1.32K	Hold	28	–	–	﹤0.01%	133
2026 Q1	$530	Hold	28	–	–	﹤0.01%	125
2025 Q4	$375	Hold	28	–	–	﹤0.01%	133
2025 Q3	$331	Hold	28	–	–	﹤0.01%	160
2025 Q2	$182	Hold	28	–	–	﹤0.01%	164
2025 Q1	$164	Hold	28	–	–	﹤0.01%	147
2024 Q4	$195	Hold	28	–	–	﹤0.01%	146
2024 Q3	$160	Hold	28	–	–	﹤0.01%	145
2024 Q2	$202	Hold	28	–	–	﹤0.01%	157
2024 Q1	$264	Hold	28	–	–	﹤0.01%	156
2023 Q4	$103	Hold	28	–	–	﹤0.01%	166
2023 Q3	$88	Buy	+28	New	+$115	﹤0.01%	178
2023 Q2	–	Sell	-28	Closed	-$89	–	186
2023 Q1	$89	Hold	28	–	–	﹤0.01%	191
2022 Q4	$62	Hold	28	–	–	﹤0.01%	181
2022 Q3	$0	Buy	+28	New	+$269	﹤0.01%	154
2022 Q2	–	Sell	-23	Closed	–	–	152
2022 Q1	$0	Buy	23 +8	+53%	+$139	﹤0.01%	162
2021 Q4	$0	Buy	15 +7	+88%	+$223	﹤0.01%	194
2021 Q3	$0	Buy	+8	New	+$346	﹤0.01%	181

Other funds holding DFTX

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Stableford Capital II Scottsdale, Arizona $288M AUM 21.3% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Robbins Farley's DFTX Position: Q3 2026 in Review

Robbins Farley held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 28 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #139.

Robbins Farley first reported a position in DFTX in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.32K in Q2 2026. 41 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

Robbins Farley held 28 shares of Definium Therapeutics worth $1.07K as of Q3 2026.
Robbins Farley left its Definium Therapeutics share count unchanged in Q3 2026.
Definium Therapeutics made up ﹤0.01% of Robbins Farley's portfolio in Q3 2026, its #139 holding.
Robbins Farley first reported a position in Definium Therapeutics in Q3 2021 and has held it in 19 quarters since.
Robbins Farley's Definium Therapeutics position peaked at $1.32K in Q2 2026.
41 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Robbins Farley's 13F filing for Q3 2026, filed 21 Oct 2026.